Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 968-976

  Leist, Marcel ^a   Auer Barth, Sigrid ^a   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; METHYLXANTHINE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE DERIVATIVE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; LIVER; MALE; METABOLISM; MOUSE; MOUSE STRAIN;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED STRAINS; TUMOR NECROSIS FACTOR-ALPHA; XANTHINES;

EID: 0030111451     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. ADACHI, Y., BRADFORD, B. U., GAO, W., BOJES, H. K. AND THURMAN, R. G.: Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20: 453-460, 1994.
2. ALEGRE, M., GASTALDELLO, K., ABRAMOWICZ, D., KINNAERT, P., VEREERSTRAETEN, P., DE PAUW, L., VANDENABEELE, P., MOSER, M., LEO, O. AND GOLDMAN, M.: Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation 52: 674-679, 1991.
3. BAHRAMI, S., REDL, H., BUURMAN, W. A. AND SCHLAG, G.: Influence of the xanthine derivate HWA 138 on endotoxin-related coagulation disturbances: Effects in non-sensitized vs D-galactosamine sensitized rats. Thromb. Haemostas. 4: 418-423, 1992.
4. BARRIAULT, C., AUDET, M., YOUSEF, I. M. AND TUCHWEBER, B.: Effect of agents which modify reticuloendothelial function on acute phalloidin-induced lethality and hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 131: 206-215, 1995.
5. BARSONY, J. AND MARX, S. J : Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. Proc. Natl. Acad. Sci. U.S.A. 87: 1188-1192, 1990.
6. BAUER, A. C. AND SCHWABE, U.: An improved assay of cyclic 3′,5′-nucleotide phosphodiesterase with QAE sephadex A25. Naunyn-Schrniedeberg's Arch. Pharmacol. 311: 193-198, 1980.
7. BEAVO, J. A., ROGERS, N. L., CROFFORD, O. B., HARDMAN, J. G., SUTHERLAND, E. W. AND NEWMAN, E. V.: Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol. Phaimacol 6: 597-603, 1970.
8. BERGMEYER, H. U.: Methods of Enzymatic Analysis, 3rd. ed., Vol. 82, Verlag Chemie, Weinheim, 1984.
9. BEUTLER, B., MILSARK, I. W. AND CERAMI, A. C.: Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effect of endotoxin. Science (Wash. DC) 229: 869-871, 1985.
10. CAMARA, D. S., CARUANA, J. A., SCHWARTZ, K A., MONTES, M. AND NOLAN, J. P.: D-galactosamine liver injury: Absorption of endotoxin and protective effect of small bowel and colon resection in rabbits (41555). Proc. Soc. Exp. Biol. Med 172: 255-259, 1983.
11. CASSATELLA, M. A.: The production of cytokines by polymorphonuclear neutrophus Immunol. Today 16: 21-26, 1995.
12. CHOJKIER, M. AND FIERER, J.: D-galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 88: 115-121, 1985.
13. COCCIA, M. T., WAXMAN, K, SOLIMAN, H., TOMINAGA, G. AND PINDERSKI, L.: Pentoxifylline improves survival following hemorrhagic shock. Crit. Care Med. 17: 36-38, 1989.
14. COLLETTI, L. M., REMICK, D. G., BURTCH, G. D., KUNKEL, S. L., STRIETER, R. M. AND CAMPBELL, D. A.: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85: 1936-1943, 1990.
15. CRUTCHLEY, D. J., CONANAN, L. B. AND QUE, B. G.: Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-α and interleukin-1-β in human monocytic THP-1 cells. J. Pharmacol. Exp. Ther. 271: 446-451, 1994.
16. CUTURI, M. C , MURPHY, M., COSTA-GIOMI, M. P., WEINMANN, R., PERUSSIA, B. AND TRINCHIERI, G.: Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med. 165: 1581-1594, 1987.
17. CZAJA, M. J., XU, J., JU, Y., ALT, E. AND SCHMIEDEBERG, P.: Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology 19: 1282-1289, 1994.
18. DECKER, K.: Biologically active products of stimulated liver macrophages (Kupffer Cells). Eur. J. Biochem. 192: 245-261, 1990.
19. DECKER, T., LOHMANN-MATHES, M. L., KARCK, U., PETERS, T. AND DECKER, K.: Comparative study of cytotoxicity, tumor necrosis factor, and protaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells and murine inflammatory liver macrophages. J. Leukocyte Biol. 45: 139-146, 1989.
20. DEZUBE, B. J., SHERMAN, M. L., FRIDOVICH-KEIL, J. L., ALLEN-RYAN, J. AND PARDEE, A. B.. Down-regulation of tumor necrosis factor expression by penxifylline in cancer patients: A pilot study. Cancer Immunol. Immunother. 36: 57-60, 1993.
21. ENDRES, S., FÜLLE, H. J., SINHA, B., STOLL, D., DINARELLO, C. A., GERZER, R. AND WEBER, P. C.: Cyclic nucleotides differentially regulate the synthesis of tumor necrosis-factor-alpha and interleukin-1-beta by human mononuclear cells. Immunology 72: 56-60, 1991.
22. ESPEVIK, T. AND NISSEN-MEYER, J.: A highly sensitive cell line WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105, 1986.
23. FISCHER, W., SCHUDT, C. AND WENDEL, A.: Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45: 2399-2404, 1993.
24. FREUDENBERG, M. A., KEPPLER, D. AND GALANOS, C.: Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51: 891-895, 1986.
25. GALANOS, C., FREUDENBERG, M. A. AND REUTTER, W.: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 76: 5939-5943, 1979.
26. GANTNER, F., LEIST, M., JILG, S., GERMANN, P. G., FREUDENBERG, M. A. AND TIEGS, G.: Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 109:166-176, 1995a.
27. GANTNER, F., LEIST, M., LOHSE, A. W., GERMANN, P. G. AND TIEGS, G.: Concanavalin A-induced T Cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 21: 190-198, 1995b.
28. GIROIR, B. P., JOHNSON, J. A., BROWN, T., ALLEN, G. AND BEUTLER, B.: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90: 693-698, 1992.
29. GONZÁLEZ-AMARO, R., GARCIA-MONZÓN, C., GARCIA-BUEY, L., MORENO-OTERO, R., ALONSO, J. L., YAGÜE, E., PIVEL, J. P., LÓPEZ-CABRERA, M., FERNANDEZ-RUIZ, E. AND SÁNCHEZ-MADRID, F.: Induction of tumor necrosis factor alpha by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179: 841-848, 1994.
30. GRAU, G. E., FAJARDO, L. F., PIGUET, P. F., ALLETT, B. AND VASSALLI, P.: Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (Wash. DC) 237: 1210-1212, 1987.
31. GRÜN, M. AND LIEHR, H.: Significance of endotoxemia in experimental "galactosamine-hepatitis" in rat Acta Hepato-Gastroenterol. 23: 64-81, 1976.
32. HAN, J., THOPSON, P. AND BEUTLER, B.: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signalling pathway. J. Exp. Med. 172: 391-394, 1990.
33. HANSEN, J., CHERWITZ, D. L. AND ALLEN, J. I.: The role of tumor necrosis factor alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 20: 461-474, 1994.
34. HARADA, H., ISHIZAKA, A., YONEMARU, M., MALLICK, A. A., HATHERILL, J. R., ZHENG, H., LILLY, C. M., O'HANLEY, P. T. AND RAFFIN, T. A.: The effects of aminophylline on multiple organ damage after Escherichia coli sepsis. Am. Rev. Respir Dis. 140: 974-980, 1989.
35. HARTUNG, T., LEIST, M., TIEGS, G., BASCHONG, W. AND WENDEL, A.: Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents. Inflammopharmacology 1: 49-60, 1991.
36. HARTUNG, T. AND WENDEL, A.: Endotoxin-inducible cytotoxicity in liver cell cultures-I. Biochem. Pharmacol. 42: 1129-1135, 1991.
37. HOLGATE, S. T., LEWIS, R. A. AND AUSTEN, K. F.: Role of adenylate cyclase in immunologic release of mediators from rat mast cells: Agonist and antagonist effects of purine- and ribose-modified adenosine analogs. Proc. Natl. Acad. Sci U.S.A. 77: 6800-6804, 1980.
38. ISHIYAMA, H., OGINO, K. AND HOBARA, T.: Role of Kupffer cells in rat liver injury induced by diethyldithiocarbamate. Eur. J. Pharmacol. 292: 135-141, 1995.
39. 2 and dexamethasone. J. Hepatol. 7: 352-361, 1988.
40. KREMSNER, P. G., GRUNDMANN, H., NEIFER, S., SLIWA, K., SAHLMÜLLER, G., HEGENSCHEID, B. AND BIENZLE, U.: Pentoxifylline prevents murine cerebral malaria. J. Infect. Dis. 164: 605-608, 1991.
41. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380-5384, 1988.
42. LASKIN, D. L: Nonparenchymal cells and hepatotoxicity. Semin. Liver Dis 10: 293-304, 1990.
43. LASKIN, D. L., GARDNER, C R., PRICE, V. F. AND JOLLOW, D. J.: Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050, 1995.
44. LEHMANN, V., FREUDENBERG, M. A. AND GALANOS, C.: Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosaminetreated mice. J. Exp. Med. 163: 657-663, 1987.
45. LEIST, M., GANTNER, F , BOHLINGER, I , TIEGS, G., GERMANN, P. G. AND WENDEL, A.: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146: 1220-1234, 1995a.
46. LEIST, M., GANTNER, F., JILG, S. AND WENDEL, A.: Activation of the 55 kDa TNF-receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J. Immunol. 154: 1307-1316, 1995b.
47. MCGUIRE, W., HILL, A. V. S., ALLSOPP, C. E. M., GREENWOOD, B. M. AND KJATKOWSKI, D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (Lond) 371: 508-511, 1994.
48. NGOZZI, M. AND GHEZZI, P., Cytokine down-regulation in endotoxin tolerance. Eur. Cytokine Network 4: 89-98, 1993.
49. MEYER, R. B. AND MILLER, J. P.: Analogs of cyclic AMP and cyclic GMP: General methods of synthesis and the relationship of structure to enzymic activity. Life Sci. 14: 1019-1040, 1974.
50. MOHLER, K. M., SLEATH, P. R., FITZNER, J. N., CERRETTI, D. P., ALDERSON, M., KERWAR, S. S., TORRANCE, D. S., OTTEN-EVANS, C., WEERAWARNA, T. G. K., KRONHEIM, S. R., PETERSEN, M., GERHART, M., KOZLOSKY, C. J., MARCH, C. J. AND BLACK, R A. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature (Lond.) 370: 218-220, 1994.
51. NANJI, A. A., ZHAO, S., SADRZADEH, S. M. H. AND WAXMAN, D. J.: Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 19: 1483-1487, 1994.
52. NEUNER, P., KLOSNER, G., SCHAUER, E., POURMOJIB, M., MACHETNEH, W., GRUNWALD, C., KNOBLER, R., SCHWARZ, A., LUGER, T. A. AND SCHWARZ, T.: Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumor necrosis factor-alpha by human peripheral blood mononoclear cells. Immunology 83: 262-267, 1994.
53. NICHOLSON, C. D., CHALISS, R. A. J. AND SHAHID, M.: Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 12: 19-27, 1991.
54. NIEHÖRSTER, M., SCHÖNHARTING, M. AND WENDEL, A.: A novel xanthine derivative counteracting in vivo tumor necrosis factor alpha toxicity in mice. Circ. Shock 37: 270-273, 1992.
55. NOLAN, J. P. AND LEIBOWITZ, A. I.: Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin B - An antiendotoxin. Gastroenterology 75: 445-449, 1978.
56. OZMEN, L., PERICIN, M., HAKIMI, J., CHIZZONITE, R. A., WYSOCKA, M., TRINCHIERI, G., GATELY, M. AND GAROTTA, G.: Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180: 907-915, 1994.
57. PARMELY, M. J., ZHOU, W., EDWARDS, C. K., BORCHERDING, D. R., SILVERSTEIN, R. AND MORRISON, D. C.: Adenosine and related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 151: 389-396, 1993.
58. PHILIP, R. AND EPSTEOT, L. B.: Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature (Lond) 323: 86-88, 1986.
59. PORAT, E. V. G. R., MIER, J. W., ORENCOLE, S. F., KAPLANSKI, G., LYNCH, E. A., YE, K., WOLFF, E. V. S. M. AND DINARELLO, C. A.: Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151: 1637-1645, 1993.
60. PRABHAKAR, U., LIPSHUTZ, D., BARTUS, J. O., SLIVJAK, M. J., SMITH, E. F., LEE, J. C. AND ESSER, K. M.: Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol. 16: 805-816, 1994.
61. PRYZWANSKY, K. B., STEINER, A. L., SPITZNAGEL, J. K. AND KAPOOR, C. L.: Compartmentalization of cyclic AMP during phagocytosis by human neutrophilic granulocytes, Science (Wash.) 211: 407-410, 1981.
62. REES, R. C AND WILTROUT, R. H.: The biology and clinical applications of interleukin-2. Immunol. Today 11: 36-38, 1990.
63. 2 receptors on rat Kupffer cells. Hepatology 19: 1445-1452, 1994.
64. RENZ, H., GONG, J., SCHMITT, A., NAIN, M AND GEMSA, D.: Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141: 2388-2393, 1988.
65. ROSENSTREICH, D. L. AND VOGEL, S. N.: Central role of macrophages in the host response to endotoxin. In Microbiology, ed. by D. Schlessinger, pp. 11-15, American Society of Microbiology, Washington, 1980.
66. HADE, U. F.: The role of prostacyclin in the protective effect of pentoxifylline and other xanthine derivatives in endotoxin action in mice. Eicosanoids 2: 183-188, 1989.
67. SCHANDENÉ, L., VANDENBUSSCHE, P., CRUSIAUX, A., ALLÈGRE, M., ABRAMOWICZ, D., DUPONT, E., CONTENT, J. AND GOLDMAN, M.: Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha and interleukin-6 by monocytes and T cells. Immunology 76: 30-34, 1992.
68. SCHÖNHARTING, M. M. AND SCHADE, U. F.: The effect of pentoxifylline in septic shock: New pharmacologic aspects of an established drug. J. Med. 20: 97-105, 1989.
69. SCHUDT, C., WINDER, S., FORDERKUNZ, S., HATZELMANN, A. AND ULLRICH, V.: Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Ca(i). Naunyn-Schmiedeberg's Arch. Pharmacol. 344: 682-690, 1991a.
70. SCHUDT, C., WINDER, S., MÜLLER, B. AND UKENA, D.: Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem. Pharmacol. 42: 153-162, 1991b.
71. SEMMLER, J., GEBERT, U., EISENHUT, T., MOELLER, J., SCHOENHARTING;, M. M., ALLÉRA, A. AND ENDRES, S.: Xanthine derivatives: Comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 78: 520-525, 1993.
72. SHIBAYAMA, Y., ASAKA, S. AND NAKATA, K.: Role of activated macrophages in augmentation of endotoxin hepatotoxicity. Exp. Toxicol. Pathol. 45: 497-502, 1993.
73. SHIRATORI, Y., KAWASE, T., SHIINA, S., OKANO, K., SUGIMOTO, T., TERAOKA, H., MATANO, S., MATSUMOTO, K. AND KAMII, K.: Modulation of hepatotoxicity by macrophages in the liver. Hepatology 8: 815-821, 1988.
74. SHIRWAN, H., COSENZA, C. A., WANG, H. K., WU, G , MAKOWKA, L. AND CRAMER, D. V.: Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Transplantation 57: 1072-1080, 1994.
75. SINHA, B., SEMMLER, J., EISENHUT, T., EIGLER, A. AND ENDRES, S.: Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25: 147-153, 1995.
76. STRIETER, R. M., REMICK, D. G., WARD, P. A., SPENGLER, R. N., LYNCH, J. P., LARRICK, J. AND KUNKEL, S. L.: Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155: 1230-1236, 1988.
77. THOMPSON, W. J. AND APPLEMAN, M. M.: Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv. Cycl. Nucl. Res. 10: 69-92, 1979.
78. TIEGS, G., HENTSCHEL, J. AND WENDEL, A.: AT cell-dependent experimental liver injury in mice inducible to concanavalin A. J. Clin. Invest. 90: 196-203, 1992.
79. TIEGS, G., WOLTER, M. AND WENDEL, A.: Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38: 627-631, 1989.
80. TRACEY, K. J. AND CERAMI, A.: Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell. Biol. 9: 317-343, 1993.
81. WANG, J. F. AND WENDEL, A.: Studies on the hepatotoxicity of galactosamine/ endotoxin or galaetosamine/TNF in the perfused mouse liver. Biochem. Pharmacol. 39: 267-270, 1990.
82. WENDEL, A., TIEGS, G. AND WERNER, C.: Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 36: 2637-2639, 1987.
83. ZABEL, P., WOLTER, D. T., SCHÖNHARTING, M. M. AND SCHADE, U. F.: Oxpentifylline in endotoxemia. Lancet II: 1474-1477, 1989.